|Bid||97.62 x 500|
|Ask||97.63 x 300|
|Day's Range||97.30 - 98.01|
|52 Week Range||96.66 - 123.55|
|PE Ratio (TTM)||25.20|
|Earnings Date||Apr 19, 2018|
|Forward Dividend & Yield||4.28 (4.27%)|
|1y Target Est||120.07|
The FDA is taking the first step toward implementing a rule about the role flavors, including menthol, play in attracting users to certain tobacco products.
Has Altria’s Stock Price Bottomed Out? As of March 20, 2018, Altria Group (MO) was trading at $61.52. After the announcement of Altria’s 4Q17 earnings, Jefferies raised its target price from $81 to $84, and RBC raised its target price from $62 to $65.
Has Altria’s Stock Price Bottomed Out? Analysts are expecting Altria Group (MO) to post EPS (earnings per share) of $3.88 in 2018, which represents a rise of 14.5% from $3.39 in 2017. Altria’s EPS growth is expected to be driven by revenue growth, expansion of net margins, and share repurchases.
Tobacco stocks are trading lower on Wednesday, after another blow from the Food and Drug Administration. The FDA issued its Advanced Notice for Proposed Rulemaking (ANPRM) for characterizing flavors in tobacco products including menthol cigarettes, signaling its intent to regulate these, in both traditional and e-cigarettes. This follows on the heels of its proposed rule for nicotine in tobacco products, released just last week.
Philip Morris International Inc. said Wednesday it has ceased all cigarette production at the facility of its Greek affiliate Papastratos, which will now only produce HEETS, the tobacco units used with ...
Philip Morris International Inc. announced today that the factory of its Greek affiliate in Aspropyrgos, has ceased cigarette production and is now exclusively producing HEETS, the tobacco units used with IQOS, the company’s most advanced smoke-free product.
The Food and Drug Administration is taking the first step toward implementing a rule about the role that flavors, including menthol, play in attracting users to certain tobacco products.
The Food and Drug Administration will consider restricting the use of menthol flavoring in cigarettes, the second move in a week by the agency to make smoking less enjoyable as part of an ambitious anti-tobacco ...
When analysts raise their target prices, stock prices tend to rise, and vice versa. Of the 17 analysts that follow Philip Morris, 58.8% are favoring a “buy,” and 41.2% are favoring a “hold.” None of the analysts are recommending a “sell.” In the next 12 months, analysts are expecting the stock to reach $120.07, which represents a return potential of 14.4%. Since the announcement of its 4Q17 earnings, Jefferies has cut its target price from $124 to $121, while Cowen and Company has reduced its target price from $133 to $120.
What Happened The U.S. Food and Drug Administration announced March 15 an Advance Notice of Proposed Rulemaking (ANPRM) to procure information to help set the maximum nicotine level for cigarettes to non-addictive ...
On March 1, 2018, Altria Group (MO) announced dividends of $0.70 per share to be paid on April 10, 2018, to shareholders of record as of March 15, 2018. Altria also rewards its shareholders with share repurchases, which reduce the number of shares outstanding, thus boosting the company’s EPS (earnings per share). The company’s management also authorized a new $1 billion share repurchase program in January 2018, which is expected to be completed in 2018.
In 4Q17, Altria Group (MO) posted EPS (earnings per share) of $2.60. The growth was driven by the expansion of net margins and by share repurchases in the last four quarters. Altria’s management has set the company’s 2018 EPS guidance at $3.90–$4.03, which represents a growth of 15%–18.9% from $3.39 in 2017.
If you are interested in cashing in on Philip Morris International Inc’s (NYSE:PM) upcoming dividend of $1.07 per share, you only have 3 days left to buy the shares beforeRead More...
Analysts are expecting Philip Morris International (PM) to post revenue of $31.9 billion in 2018, which represents a rise of 11% from $28.8 billion in 2017. The company’s management expects currency-neutral revenue growth at approximately 8%. Revenue growth is expected to be driven by an increase in product prices and growth in RRP (reduced risk products) sales.
In 4Q17, Philip Morris International (PM) posted net revenue of $8.3 billion, which represents growth of 19% from $7 billion in 4Q16. Growth was driven by an increase in total shipment volume of 3.8% and favorable pricing. Philip Morris had a strong performance in the European Union, Asia, Latin America, and Canada.
WASHINGTON (AP) — Federal health officials took the first step Thursday to slash levels of addictive nicotine in cigarettes, an unprecedented move designed to help smokers quit and prevent future generations from getting hooked.
Philip Morris International Inc (NYSE:PM) is trading with a trailing P/E of 27.2x, which is higher than the industry average of 18x. While PM might seem like a stock toRead More...
U.S. health officials took the first concrete steps toward cutting the nicotine content in cigarettes to nonaddictive levels, opening a public inquiry ahead of proposed regulations to lower nicotine levels....
The U.S. Food and Drug Administration is seeking public opinion as well as scientific research on the role nicotine plays in cigarette addiction, the agency said on Thursday, as it aims to lower tobacco-related deaths across the country. The latest steps are part of a comprehensive plan to regulate tobacco and nicotine that the agency announced last summer, FDA Commissioner Scott Gottlieb said in a statement https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm601039.htm. The FDA is seeking additional research and data for public review, Gottlieb said, as the agency deliberates on developing a nicotine product standard.
NEW YORK, NY / ACCESSWIRE / March 15, 2018 / U.S. markets' slide extended on Wednesday as concerns over a potential trade war with China continues to grow. The Dow Jones Industrial Average dropped 1.00 ...